Samet Kocaturk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samet Kocaturk has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- James M. Tepper
Rutgers University
2 shared publications - Dalton James Surmeier
Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
1 shared publication - Elif B. Guven
Molecular and Behavioral Neuroscience, Rutgers University, Newark, NJ, USA
1 shared publication Elif Beyza Guvern
1 shared publication- Ema Ilijic
Department of Neuroscience, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
1 shared publication Jay Li
Department of Internal Medicine, University of Michigan Medical School. Ann Arbor, MI, USA
1 shared publication
Latest Publications
- Open Access
- 27 July 2026
- Published by Elsevier in SSRN Electronic Journal
Long-Range Inhibitory Control of Cholinergic Network Dynamics in the Striatum
Striatal cholinergic interneurons (CINs) exhibit a transient pause in tonic firing in response to salient stimuli, a hallmark of reinforcement learning that becomes synchronized with learning. Although thalamostriatal and dopaminergic inputs have been implicated in this pause, the underlying circuit mechanisms remain unclear. Here, we combine optogenetics, electrophysiology, and genetic approaches to examine inhibitory interactions within the CIN network. Synchronized activation of CINs in striatal slices elicited robust feedback inhibition in CINs, suppressing firing and generating pause-like responses. This inhibition was mediated by GABAA receptors and required β2-containing nicotinic acetylcholine receptors (β2-nAChR), and could be recruited by thalamostriatal activation. Dopamine is not required for this circuit but modulates it via D2 receptors. Surprisingly, cell-type–specific silencing and striatal β2-nAChR deletion excluded local GABAergic sources, whereas retrograde β2-nAChR deletion abolished inhibition, revealing an extrastriatal pathway. These findings identify a long-range inhibitory mechanism linking synchronized cholinergic activity to pause generation in striatal circuits.
- 27 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLong-Range Inhibitory Control of Cholinergic Network Dynamics in the Striatum
Striatal cholinergic interneurons (CINs) exhibit a transient pause in tonic firing in response to salient stimuli, a hallmark of reinforcement learning that becomes synchronized with learning. Although thalamostriatal and dopaminergic inputs have been implicated in this pause, the underlying circuit mechanisms remain unclear. Here, we combine optogenetics, electrophysiology, and genetic approaches to examine inhibitory interactions within the CIN network. Synchronized activation of CINs in striatal slices elicited robust feedback inhibition in CINs, suppressing firing and generating pause-like responses. This inhibition was mediated by GABAA receptors and required β2-containing nicotinic acetylcholine receptors (β2-nAChR), and could be recruited by thalamostriatal activation. Dopamine is not required for this circuit but modulates it via D2 receptors. Surprisingly, cell-type–specific silencing and striatal β2-nAChR deletion excluded local GABAergic sources, whereas retrograde β2-nAChR deletion abolished inhibition, revealing an extrastriatal pathway. These findings identify a long-range inhibitory mechanism linking synchronized cholinergic activity to pause generation in striatal circuits.
- Open Access
Cholinergic interneuron control of GABAergic circuits targeting spiny projection neurons is disrupted in parkinsonian models
Parkinson's disease (PD) is known to alter the intrinsic properties of striatal cholinergic interneurons (ChIs). However, how PD shapes ChI control of intrastriatal GABAergic circuits regulating principal spiny projection neurons (SPNs) is unknown. To fill this gap, striatal circuits in healthy and parkinsonian mice were interrogated. In ex vivo brain slices from healthy mice, optogenetic stimulation of ChIs evoked GABA A receptor currents in both indirect and direct pathway SPNs that were attributable to nicotinic acetylcholine receptor (nAChR)-mediated activation of GABAergic interneurons (GIs). Simulations suggested that this circuit exerts a state-dependent control of SPN dendritic integration that was modulated by concomitant muscarinic receptor signaling. Surprisingly, in mouse models of prodromal and parkinsonian states, the ability of ChIs to engage this intrastriatal circuitry was disrupted because interneurons down-regulated nicotinic AChRs. Taken together, these studies suggest that impaired ChI control of GABAergic interneurons contributes to behavioral deficits in both prodromal and clinical PD states.
Open AccessCholinergic interneuron control of GABAergic circuits targeting spiny projection neurons is disrupted in parkinsonian models
Parkinson's disease (PD) is known to alter the intrinsic properties of striatal cholinergic interneurons (ChIs). However, how PD shapes ChI control of intrastriatal GABAergic circuits regulating principal spiny projection neurons (SPNs) is unknown. To fill this gap, striatal circuits in healthy and parkinsonian mice were interrogated. In ex vivo brain slices from healthy mice, optogenetic stimulation of ChIs evoked GABA A receptor currents in both indirect and direct pathway SPNs that were attributable to nicotinic acetylcholine receptor (nAChR)-mediated activation of GABAergic interneurons (GIs). Simulations suggested that this circuit exerts a state-dependent control of SPN dendritic integration that was modulated by concomitant muscarinic receptor signaling. Surprisingly, in mouse models of prodromal and parkinsonian states, the ability of ChIs to engage this intrastriatal circuitry was disrupted because interneurons down-regulated nicotinic AChRs. Taken together, these studies suggest that impaired ChI control of GABAergic interneurons contributes to behavioral deficits in both prodromal and clinical PD states.